Price movement over the last 24 hours
Agilent Technologies Inc vs ArcelorMittal SA — how do they compare? Agilent Technologies Inc trades at $128.35 (market cap $37.04B), while ArcelorMittal SA trades at $61.73 (market cap $48.35B). The key difference: ArcelorMittal SA is the larger of the two by market cap, and ArcelorMittal SA pays the higher dividend (0.95%). Which is the better fit depends on your goals.
| A | MT | |
|---|---|---|
Market Cap | $37.04B | $48.35B |
Sector | Health | Basic Materials |
52-Week High | $157.20 | $71.65 |
52-Week Low | $110.24 | $30.39 |
Enterprise Value | $38.59B | $57.67B |
Dividend Yield | 0.78% | 0.95% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
ArcelorMittal (MT) trades at $63.15, down 0.39% on the day, with a bullish technical signal supported by moving averages. The stock shows strong earnings momentum, beating estimates for three consecutive quarters, and maintains a reasonable valuation with a P/E of 17.11 and P/S of 0.81. Recent news highlights expansion initiatives, a share buyback program, and a strategic AI collaboration with AWS to drive efficiency and lower-carbon steel production.
The outlook for MT is positive, driven by operational expansions and favorable steel import policies in Europe and the US, though risks include high capital expenditures and exposure to Chinese market weakness. Analyst sentiment is predominantly bullish with 50% buy ratings, supporting potential upside if earnings growth continues.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →